Etomidate as an induction agent increases mortality in critically ill patients?
Etomidate is a widely-used agent in rapid sequence induction for endotracheal intubation in critically ill patients. It’s also known to cause adrenal suppression, but the clinical significance of this side effect has never been definitively established. Numerous randomized trials have raised suspicion but failed to prove harm caused by etomidate.
A meta…
Keep reading with a 7-day free trial
Subscribe to PulmCCM to keep reading this post and get 7 days of free access to the full post archives.